Evidence map›Paper›PMID 34560175›Full record

ReviewNeurochemistry international2021

Rescuing mitochondria in traumatic brain injury and intracerebral hemorrhages - A potential therapeutic approach.

Meenakshi Ahluwalia, Manish Kumar, Pankaj Ahluwalia, Scott Rahimi, John R Vender, Raghavan P Raju, David C Hess, Babak Baban, Fernando L Vale, Krishnan M Dhandapani and 1 more

Open access · greenAbstract readReview
In one paragraph

Review in Neurochemistry international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Tetramerization of PKM2 Alleviates Traumatic Brain Injury by Ameliorating Mitochondrial Damage in Microglia.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Meenakshi AhluwaliaDepartment of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA. Electronic address: mahluwalia@augusta.edu.
Manish KumarDepartment of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Pankaj AhluwaliaDepartment of Pathology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Scott RahimiDepartment of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.
John R VenderDepartment of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Raghavan P RajuDepartment of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
David C HessDepartment of Neurology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Babak BabanDepartment of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA, USA.
Fernando L ValeDepartment of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Krishnan M DhandapaniDepartment of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Kumar VaibhavDepartment of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA; Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA, USA. Electronic address: kvaibhav@augusta.edu.
Augusta University · US

Funding

Therapeutic Targeting of Monoacylglycerol Lipase After Traumatic Brain InjuryR01NS114560 · NINDS · AUGUSTA UNIVERSITY · PI VAIBHAV, KUMAR · 2020 to 2024
$1.8M
HMGB1 and Traumatic Brain InjuryR01NS065172 · NINDS · AUGUSTA UNIVERSITY · PI DHANDAPANI, KRISHNAN M. · 2009 to 2013
$1.6M
Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID ModelR01NS099455 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2017 to 2020
$1.5M
Neutrophil Activation after Traumatic Brain InjuryR01NS110378 · NINDS · AUGUSTA UNIVERSITY · PI ARBAB, ALI SYED, BABAN, BABAK · 2019 to 2022
$1.5M
Rheoerythrocrine dysfunction in stroke and remote ischemic conditioning (REDS)R01NS112511 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2020 to 2023
$1.3M
Remote Ischemic Conditioning: A collateral therapeutic and neuroprotectantU01NS113356 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2019 to 2021
$1.1M
Neutrophil extracellular traps and TBIR56NS097825 · NINDS · AUGUSTA UNIVERSITY · PI BABAN, BABAK, DHANDAPANI, KRISHNAN M. · 2017 to 2017
$380k
NINDS NIH HHS R01 NS065172NINDS NIH HHS R01 NS099455NINDS NIH HHS R01 NS110378NINDS NIH HHS R01 NS112511NINDS NIH HHS R01 NS114560NINDS NIH HHS R56 NS097825NINDS NIH HHS U01 NS113356
6 · The paper itself

Abstract

Mitochondria are dynamic organelles responsible for cellular energy production. Besides, regulating energy homeostasis, mitochondria are responsible for calcium homeostasis, signal transmission, and the fate of cellular survival in case of injury and pathologies. Accumulating reports have suggested multiple roles of mitochondria in neuropathologies, neurodegeneration, and immune activation under physiological and pathological conditions. Mitochondrial dysfunction, which occurs at the initial phase of brain injury, involves oxidative stress, inflammation, deficits in mitochondrial bioenergetics, biogenesis, transport, and autophagy. Thus, development of targeted therapeutics to protect mitochondria may improve functional outcomes following traumatic brain injury (TBI) and intracerebral hemorrhages (ICH). In this review, we summarize mitochondrial dysfunction related to TBI and ICH, including the mechanisms involved, and discuss therapeutic approaches with special emphasis on past and current clinical trials.

Indexed as

AnimalsAutophagyBrain Injuries, TraumaticCerebral HemorrhageEnergy MetabolismFree Radical ScavengersHomeostasisHumansHypoglycemic AgentsMitochondriaMitophagyNeuroprotective AgentsOxidative StressFree Radical ScavengersHypoglycemic AgentsNeuroprotective AgentsBrain injuryImmune activationMitochondrial bioenergeticsMitochondrial biogenesisMitophagyTherapeutic approach

Identifiers

PMID34560175
PMCPMC8542401
OpenAlexW3200834089

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.